DE1928518A1 - Pharmazeutische Masse - Google Patents

Pharmazeutische Masse

Info

Publication number
DE1928518A1
DE1928518A1 DE19691928518 DE1928518A DE1928518A1 DE 1928518 A1 DE1928518 A1 DE 1928518A1 DE 19691928518 DE19691928518 DE 19691928518 DE 1928518 A DE1928518 A DE 1928518A DE 1928518 A1 DE1928518 A1 DE 1928518A1
Authority
DE
Germany
Prior art keywords
compound
salt
mercaptopurine
mycophenolic acid
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691928518
Other languages
German (de)
English (en)
Inventor
Franklin Trevor John
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB968969A external-priority patent/GB1203328A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE1928518A1 publication Critical patent/DE1928518A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19691928518 1968-06-04 1969-06-04 Pharmazeutische Masse Pending DE1928518A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB968969A GB1203328A (en) 1968-06-04 1968-06-04 Pharmaceutical compositions
GB2656268 1968-06-04
GB4928368 1968-10-17

Publications (1)

Publication Number Publication Date
DE1928518A1 true DE1928518A1 (de) 1970-09-17

Family

ID=27255411

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691928518 Pending DE1928518A1 (de) 1968-06-04 1969-06-04 Pharmazeutische Masse

Country Status (4)

Country Link
BE (1) BE733669A (enrdf_load_stackoverflow)
DE (1) DE1928518A1 (enrdf_load_stackoverflow)
FR (1) FR2010136A2 (enrdf_load_stackoverflow)
NL (1) NL6908349A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75219B (enrdf_load_stackoverflow) * 1980-04-21 1984-07-13 Merck & Co Inc
US4853373A (en) * 1986-09-15 1989-08-01 Livingston William S Therapeutic treatment for arthritic condition

Also Published As

Publication number Publication date
FR2010136A2 (fr) 1970-02-13
BE733669A (enrdf_load_stackoverflow) 1969-11-27
NL6908349A (enrdf_load_stackoverflow) 1969-12-08

Similar Documents

Publication Publication Date Title
DE60202278T2 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
EP0240829A2 (de) Cancerostatisches Mittel
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE3343934A1 (de) M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels
CH654212A5 (de) Zubereitung zur steigerung der therapeutischen wirkung eines antitumormittels und diese zubereitung enthaltende antitumor-zubereitung.
EP0398165B1 (de) Kombinationspräparate enthaltend Rifampicin und Thioacetazon sowie gegebenenfalls Isonicotinsäurehydrazid oder Ethambutol als aktive Wirkstoffe
DE3311922C2 (de) Verwendung von substituierten 1,4-Benzochinonen bei der Prophylaxe oder Behandlung von Fibrose
DE19726871C1 (de) Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe
DE2715384C3 (de) Arzneimittel gegen Diarrhöen
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE2325070A1 (de) Pharmazeutische zubereitungen zur prophylaxe und zur behandlung von kapillarvenoesen erkrankungen
DE1928518A1 (de) Pharmazeutische Masse
DE69018022T2 (de) Magnesiumcitrat als Diätzusatzmittel.
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE3153623C2 (enrdf_load_stackoverflow)
DE2525064C2 (de) Arzneimittel mit Antiparkinson-Wirkung
DE69325512T2 (de) Verwendung von remacemid zur behandlung des morbus parkinson
DE1667903C3 (de) Verwendung von Cysteinderivaten zur Herstellung von per oral verabreichbaren Mitteln zur Bekämpfung der Seborrhoe
DE3643001C2 (enrdf_load_stackoverflow)
DE3728367C1 (de) Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
DE3511236C2 (enrdf_load_stackoverflow)
EP0094644B1 (de) Verwendung eines Cholecalciferolderivates
DE1767540C2 (de) Mittel zur Behandlung von Histomoniasis bei der Geflügelzucht
DE2314387B2 (de) Arzneimittel zur Behandlung bösartiger Neubildungen